CARBYLAN THERAPEUTICS INC's ticker is CBYL and the CUSIP is 141384107. A total of 32 filers reported holding CARBYLAN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $63,000 | – | 17,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,178,941 | $4,209,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,428,000 | 0.18% |
| PURA VIDA INVESTMENTS, LLC | 80,000 | $286,000 | 0.16% |
| MENTA CAPITAL LLC | 32,229 | $115,000 | 0.02% |
| WEDBUSH SECURITIES INC | 22,300 | $80,000 | 0.02% |
| Omega Advisors Inc. | 98,200 | $351,000 | 0.01% |
| VANGUARD GROUP INC | 5,091,482 | $170,165,000 | 0.01% |
| Alyeska Investment Group, L.P. | 109,241 | $390,000 | 0.01% |
| PUTNAM INVESTMENTS LLC | 635,468 | $2,269,000 | 0.01% |
| Pentwater Capital Management LP | 114,255 | $408,000 | 0.00% |